fluorodeoxyglucose f18 has been researched along with Peritoneal Carcinomatosis in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (1.91) | 18.2507 |
2000's | 34 (21.66) | 29.6817 |
2010's | 84 (53.50) | 24.3611 |
2020's | 36 (22.93) | 2.80 |
Authors | Studies |
---|---|
Duan, H; Lu, R; Wang, S; Xie, R; Xu, D | 1 |
Anderson, MA; Blaszkowsky, LS; Caravan, P; Catalano, OA; Clark, JW; Crafa, F; Cusack, JC; Esfahani, SA; Ferrone, CR; Franses, JW; Furtado, FS; Goyal, L; Hahn, PF; Hong, TS; Kilcoyne, A; Mahmood, U; Mojtahed, A; Qadan, M; Rosen, BR; Ryan, DP; Striar, RM; Tanabe, KK; Vangel, M; Weekes, CD; Wo, JY; Wu, MZ | 1 |
Cheng, C; Dong, A; Zhang, L; Zhang, Z; Zuo, C | 1 |
Wu, Q; Xu, X | 1 |
Goenka, AH; Rajamohan, N | 1 |
Alçın, G; Baloğlu, MC; Çermik, TF; Şahin, R; Tatar, G | 1 |
Duvivier, A; Goyers, JF; Namur, G; Radermacher, J | 1 |
Jiang, Z; Li, D; Liu, W; Xiang, L; Yang, C; Zhou, H | 1 |
Argiriadi, P; Babb, JS; Bekhor, EY; Gavane, S; Ghesani, M; Heiba, S; Labow, DM; Law, A; Taouli, B; Vietti Violi, N | 1 |
Tirumani, SH | 1 |
Akagi, K; Dono, K; Ikenaga, M; Imamura, H; Iwazawa, T; Kawase, T; Noura, S; Odagiri, K; Sato, Y; Shimizu, J; Suzuki, Y; Takeyama, H; Tomita, N; Yamashita, M; Yanagimoto, Y | 1 |
Hu, S; Li, J; Yang, J | 1 |
Choi, MC; Jang, SJ; Kim, T; Lee, JW; Lee, SM | 1 |
Chen, X; Guo, Z; Jakobsson, V; Lin, R; Miao, W; Wang, C; Wen, X; Wu, X; Yang, Y; Zang, J; Zhang, J; Zhao, T | 1 |
Iwata, J; Matsumoto, M; Murokawa, T; Okabayashi, T; Ozaki, K; Sakamoto, S; Sui, K; Tabuchi, M; Yoshida, H | 1 |
Lyburn, I; Nawwar, A; Robinson, E; Searle, J | 1 |
Hildebrandt, MG; Jensen, PT; Mogensen, O; Sponholtz, SE | 1 |
Bremers, AJA; de Geus-Oei, LF; de Wilt, JHW; Elekonawo, FMK; Heijmen, L; Laurens, ST; Starremans, B | 1 |
Hamanaka, Y; Hamanishi, J; Ishimori, T; Kido, A; Nakamoto, Y; Saga, T; Togashi, K; Watanabe, M | 1 |
Hashimoto, J; Ichikawa, T; Ikoma, H; Kodama, E; Kodama, T | 1 |
Liu, Y | 2 |
Di Renzo, C; Fiel, MI; Kozuch, DE; Schwartz, ME; Tabrizian, P | 1 |
Cheng, W; Hou, G; Jiang, Y; Wu, F; Zhang, W; Zhu, Z | 1 |
Aggarwal, A; Goel, S; Gupta, M; Iqbal, A; Rao, A; Singh, S | 1 |
He, H; Lu, RC; She, B; Shi, H; Wang, SB; Xie, R; Xv, DD; Yang, ZH | 1 |
Kobayashi Shimizu, S; Koyama, K; Nishida, N; Okamura, T; Seura, H | 1 |
Cao, J; Chen, Y; Hu, J; Xu, T; Zhang, X | 1 |
Bendifallah, S; Body, G; Bricou, A; Collinet, P; Delvallée, J; Huchon, C; Lavoue, V; Ouldamer, L; Rossard, L; Touboul, C | 1 |
Chen, H; Pang, Y; Zhao, L | 1 |
Chen, H; Guo, W | 1 |
Carnahan, MB; Conley, CR; Larsen, JT; Yang, M | 1 |
Goto, Y; Iwase, T; Tanaka, H | 1 |
Andersen, G; Blaakaer, J; Bouchelouche, K; Iversen, LH; Marinovskij, E; Mikkelsen, MS; Petersen, LK; Rosenkilde, M | 1 |
Ahlström, H; Bergman, A; Jónsdóttir, B; Poromaa, IS; Ripoll, MA; Silins, I; Stålberg, K | 1 |
Chantalat, E; Ferron, G; Gabiache, E; Martinez, A; Zerdoud, S | 1 |
Angeles, MA; Barranger, E; Betrian, S; Cabarrou, B; Chantalat, E; Chardin, D; Ducassou, A; Ferron, G; Frigenza, M; Gabiache, E; Mallet, E; Martinez, A; Martínez-Gómez, C; Motton, S; Navarro, AS; Tanguy Le Gac, Y; Viau, P | 1 |
Dwyer, JP; Khan, SA; Vaughan, R | 1 |
Kim, JH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY | 1 |
Amaya, K; Kaji, M; Maeda, K; Matsui, K; Mochizuki, K; Saito, J; Shimizu, K; Takeshita, M; Terai, S; Tsukada, T; Uchiyama, A; Watanabe, T | 1 |
Cervino, AR; Evangelista, L; Pintacuda, G; Ramondo, G; Rossi, CR; Sommariva, A | 1 |
Gao, D; Guan, Z; Huang, F; Jin, J; Li, K; Luo, G; Wang, X; Wang, Y; Yang, C; Zhang, J; Zhao, Y; Zhao, Z; Zhu, J | 1 |
Ariake, K; Fukase, K; Hayashi, H; Maeda, S; Masuda, K; Mizuma, M; Motoi, F; Naitoh, T; Ohtsuka, H; Shimomura, H; Takadate, T; Taki, Y; Tatewaki, Y; Terao, C; Unno, M | 1 |
Abraham-Nordling, M; Palmer, G; Suzuki, C; Wallgren, H | 1 |
An, H; Chang, C; Chiu, K; Lee, EYP | 1 |
Bal, A; Kumar, R; Mittal, BR; Parihar, AS; Singh, H; Sinha, SK; Vadi, SK | 1 |
Cheng, J; Feng, Z; Liu, S; Lu, L; Sun, Y; Wang, M; Xu, J; Yuan, H; Zhang, Y | 1 |
Hoogendam, JP; Roze, JF; Scholten, RJ; Spijker, R; van de Wetering, FT; Veldhuis, WB; Verleye, L; Vlayen, J; Zweemer, RP | 1 |
Gawde, S; Kasat, A; Parekh, S; Ramaswamy, V; Singhal, A | 1 |
Gohda, Y; Hotta, M; Igari, T; Minamimoto, R; Yano, H | 1 |
Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
Claver, MA; Frutos, L; Ibáñez, MJ; Reyes, RH | 1 |
Cheng, D; Shi, H; Xiao, J; Xiu, Y; Yin, H | 1 |
Beets-Tan, RGH; Donswijk, ML; Jóźwiak, K; Kusters, M; Lahaye, MJ; Lambregts, DMJ; Maas, M; Min, LA; Roberti, S; Vegt, E; Vogel, WV; Zijlmans, HJ | 1 |
Hausauer, B; Islam, Z; Keshavamurthy, J; Pucar, D | 1 |
Aloia, TA; Chasen, B; Dioun, S; Erwin, W; Fleming, N; Frumovitz, M; Lu, KH; Ramirez, PT; Soliman, PT; Stewart, KI; Westin, SN; Wong, F | 1 |
Abikhzer, G; Arkovitz, M; Gourevich, K; Keidar, Z; Postovsky, S | 1 |
Cabral, FC; Jagannathan, JP; Kim, KW; Krajewski, KM; Ramaiya, NH | 1 |
Nakamoto, Y; Nakatani, K; Togashi, K | 1 |
Aschoff, P; Beckert, S; Claussen, CD; Klumpp, B; Koenigsrainer, A; Koenigsrainer, I; Miller, S; Pfannenberg, C; Schwenzer, N | 1 |
Hong, JH; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
Barizzi, J; Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
Beckert, S; Claussen, CD; Gatidis, S; Klumpp, B; Koenigsrainer, A; Koenigsrainer, I; Mueller, M; Pfannenberg, C; Schwenzer, NF | 1 |
Domènech-Vilardell, A; Ichise, M; Rasiej, MJ; Taub, RN | 1 |
Agrawal, K; Bomanji, J; Groves, A; Saad, ZZ; Sajjan, RS; Syed, R | 1 |
Le, BB; Nguyen, BD | 1 |
Brendle, C; Claussen, CD; Gatidis, S; Königsrainer, I; Müller, M; Pfannenberg, AC; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
Agrawal, A; Purandare, NC; Puranik, AD; Rangarajan, V; Shah, S | 1 |
Kanda, M; Ohara, N; Sonoyama, A | 1 |
Choi, JY; Jung, HK; Jung, SA; Kim, SE; Shim, KN; Yoo, K | 1 |
Burdan, F; Janczarek, M; Mocarska, A; Starosławska, E; Walczewska, M; Żelazowska-Cieślińska, I | 1 |
Achtari, C; Meuli, RA; Prior, JO; Schmidt, S | 1 |
Jiang, C; Lei, J; Li, J; Yan, R | 1 |
Gong, LL; Li, XX; Liu, NB; Ren, P; Wang, P; Xu, WG; Yang, CW; Yuan, XK; Zhao, LJ; Zhu, L | 1 |
Audollent, R; Dohan, A; Eveno, C; Jouvin, I; Pocard, M; Sarda, L; Soyer, P | 1 |
Akyel, R; Ekmekcioglu, O; Ozbayrak, M; Sonmezoglu, K; Vatankulu, B | 1 |
Bae, JM; Cho, YS; Choe, YS; Kim, BT; Kim, S; Kim, SJ; Lee, KH; Moon, SH | 1 |
Dong, A; He, T; Wang, Y; Zhang, L; Zuo, C | 1 |
Bakrin, N; Dubreuil, J; Giammarile, F; Glehen, O; Isaac, S; Passot, G; Rousset, P; Skanjeti, A | 1 |
Asa, S; Gungor, S; Kupik, O | 1 |
Yoon, SN | 1 |
Andrade, RJ; Cascales-Campos, PA; Feliciangeli, E; Frutos, L; Fuster-Quiñonero, M; Gil, E; Gil, J; Lopez-Lopez, V; Parrilla, P | 1 |
Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Ponzo, F; Raad, RA; Rosenkrantz, AB | 1 |
Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A | 1 |
Fujihata, S; Kitagami, H; Kondo, Y; Miyai, H; Nonoyama, K; Shimizu, Y; Tanaka, M; Watanabe, K; Yamamoto, M; Yasuda, A | 1 |
Hu, J; Ji, YH; Lv, L; Shou, T; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
Beeke, C; Chen, J; Karapetis, C; Kumar, R; Padbury, R; Price, T; Ullah, S; Wong, GYM | 1 |
Bouazza, F; Covas, A; Deleporte, A; El Nakadi, I; Flamen, P; Garcia, C; Hendlisz, A; Lecocq, C; Liberale, G; Muylle, K | 1 |
Bakrin, N; Dubreuil, J; Giammarile, F; Glehen, O; Isaac, S; Passot, G; Rousset, P; Rubello, D; Skanjeti, A | 1 |
Chen, CJ; Chiu, NT; Chou, CY; Lee, BF; Wu, PS; Yao, WJ | 1 |
Aschoff, P; Beckert, S; Brücher, BL; Glatzle, J; Hartmann, JT; Königsrainer, A; Königsrainer, I; Miller, S; Pfannenberg, C; Schroeder, TH; Zieker, D | 1 |
Hyun, IY; Kim, SG | 1 |
Hwang, JH; Kim, SE; Lee, JK | 1 |
Aschoff, P; Beckert, S; Brücher, BL; Claussen, CD; Glatzle, J; Königsrainer, A; Königsrainer, I; Nieselt, K; Oksüz, MO; Pfannenberg, C; Symons, S; Weyhern, CV; Zieker, D | 1 |
Bellomi, M; Bonello, L; Funicelli, L; Landoni, F; Travaini, LL; Trifirò, G | 1 |
Cotte, E; Giammarile, F; Gilly, FN; Glehen, O; Isaac, S; Mohamed, F; Passot, G; Pellet, O; Tychyj, C | 1 |
Anthony, MP; Khong, PL; Zhang, J | 1 |
Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T | 1 |
Humm, JL; Li, XF; Ling, CC; Ma, Y; O'Donoghue, JA; Sun, X | 1 |
Cao, Y; Hu, YY; Huang, JH; Li, CX; Liu, QY; Zhang, WD | 1 |
Makis, W; Stern, J | 1 |
Berthelot, C; Boucher, Y; Girault, S; Le Jeune, JJ; Lorimier, G; Morel, O; Moroch, J; Poirier, AL; Verrièle, V | 1 |
Araki, T; Ichikawa, T; Kimura, K; Motosugi, U; Sano, K; Satoh, Y; Sou, H | 1 |
Cromer, M; Levine, EA; Rohani, P; Russell, GB; Scotti, SD; Shen, P; Stewart, JH | 1 |
Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
Hickeson, M; Makis, W; Rakheja, R | 1 |
Campos, PA; Gil, J; Parrilla, P | 1 |
Hong, JH; Kim, SE; Lee, JK; Lee, KW; Lee, NW; Song, SH | 1 |
Briggs, RH; Chowdhury, FU; Lodge, JP; Scarsbrook, AF | 1 |
Belloli, S; Capobianco, A; Cottone, L; Fazio, F; Manfredi, AA; Moresco, RM; Rovere-Querini, P; Valtorta, S | 1 |
Alford, S; Chander, S; Choong, P; Chu, J; Henderson, M; Ngan, S; Powell, G; Williams, S | 1 |
Shah, MA; Smyth, EC | 1 |
Aflalo-Hazan, V; Aparicio, T; Barrau, V; Benamouzig, R; Des Guetz, G; Douard, R; Eder, V; Mehanna, Z; Pop, G; Rust, E; Soussan, M; Wind, P | 1 |
Alexander, HR; Cao, Q; Chen, W; Dilsizian, V; Hausner, PF; Heath, J; Lu, M | 1 |
Aschoff, P; Bruecher, B; Claussen, CD; Klumpp, BD; Koenigsrainer, A; Kramer, U; Miller, S; Pfannenberg, C; Schwenzer, N | 1 |
Reyhan, M; Yapar, AF | 1 |
Bongaerts, AH; Glaudemans, AW; van Rheenen, RW | 1 |
Lee, H; Lee, HJ; Luci, JJ; Nam, KT; Peterson, TE; Price, RR; Tantawy, MN | 1 |
Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, JH; Park, MR; Park, MS; Shim, HJ | 1 |
Kaneko, K; Masunari, S; Omagari, J; Yoshida, T | 1 |
Altini, C; Giganti, M; Merenda, N; Niccoli Asabella, A; Notaristefano, A; Rubini, D; Rubini, G; Stabile Ianora, AA | 1 |
Bagni, O; D'Arienzo, M; Filippi, L; Salvatori, R; Scopinaro, F | 1 |
Astoul, P; Berdah, S; Dutau, H; Laroumagne, S; Maldonado, F; Roca, E; Vandemoortele, T | 1 |
Ahn, BC; Gayed, IW; Kim, HW; Won, KS; Zeon, SK | 1 |
Lin, EC | 1 |
Kanai, M; Kawai, Y; Nakamoto, Y; Takabayashi, A; Taki, Y; Tanaka, T | 1 |
Constable, CJ; Eade, TN; Fulham, MJ | 1 |
Drieskens, O; Gysen, M; Mortelmans, L; Stroobants, S; Vandenbosch, G; Vergote, I | 1 |
Larson, SM; Macapinlac, HA; Salmon, AS; Turlakow, A; Yeung, HW | 1 |
Hirahara, F; Inoue, T; Kawano, T; Lee, J; Miyagi, E; Nakagami, Y; Shimada, H; Suzuki, A; Takahashi, N; Togo, S | 1 |
Boardman, CH; Fey, GL; Lopatina, OA; Spottswood, SE | 1 |
Bueno, JG; Domínguez Grande, ML; Fernández, JP; Kosvintseva, O; Oromendía, AO; Pozo, MA; Suárez, AM; Zomeño, M | 1 |
Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
Berr, F; Caca, K; Kluge, R; Mössner, J; Müller, D; Sabri, O; Wiedmann, M | 1 |
Gotoh, Y; Higashi, T; Ishibashi, K; Kawasaki, A; Morita, H; Yamaguchi, Y; Yamasaki, M | 1 |
Even-Sapir, E; Hain, D; Metser, U; Zissin, R | 1 |
Banayan, S; Billotey, C; Hot, A; Janier, M; Ninet, J; Zurlinden, O | 1 |
Gupta, P | 1 |
Lo, KW | 1 |
Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
Bruno, GL; Lilien, DL; Reddy, M; Takalkar, AM | 1 |
Berthelsen, AK; Hillingsoe, J; Kirkegaard, P; Larsen, PN; Loft, A; Mogensen, AM; Rappeport, ED; Rasmussen, A; Thomsen, C; von der Recke, P; Wettergren, A | 1 |
Fleshman, JW; Strasberg, SM; Yang, YY | 1 |
Klippenstein, DL; Lamonica, DM | 1 |
Aozasa, K; Hamada, K; Hatazawa, J; Higuchi, I; Nonomura, N; Okuyama, A; Shimamoto, H; Tomita, Y; Tsujihata, M | 1 |
Dirisamer, A; Haller, J; Heinisch, M; Langsteger, W; Lehner, HP; Schima, W; Weber, M | 1 |
Jeong, HJ; Kim, DW; Lim, ST; Sohn, MH; Yim, CY | 1 |
Hosokawa, C; Iwata, H; Kawabe, J; Kobashi, T; Ochi, H; Okamura, T; Shimonishi, Y; Wada, S | 1 |
Ishida, H; Kimura, T; Makuuchi, H; Mukai, M; Sadahiro, S; Shohtsu, A; Tajima, T; Tokunaga, N; Yasuda, S | 1 |
Akhurst, T; Blumgart, LH; Cohen, A; Finn, RD; Fong, Y; Kemeny, N; Larson, SM; Macapinlac, H; Saldinger, PF; Yeung, H | 1 |
Li, YF; Liu, RS; Ng, HT; Wang, PH; Yuan, CC | 1 |
Dörffler, W; Haller, U; Köchli, OR; Kubik-Huch, RA; Marincek, B; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
Lear, J; Lin, EC; Quaife, RA | 1 |
Abdul-Karim, FW; Faulhaber, P; Miraldi, F; Rose, PG | 1 |
Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H; Yamaguchi, A | 1 |
11 review(s) available for fluorodeoxyglucose f18 and Peritoneal Carcinomatosis
Article | Year |
---|---|
The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
Topics: Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
[Diagnosis of benign ovarian lesions using imaging techniques].
Topics: Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Ovarian Diseases; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms | 2017 |
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Laparoscopy; Patient Selection; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2008 |
Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Granulocyte Colony-Stimulating Factor; Humans; Leukocytosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2011 |
Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
5 trial(s) available for fluorodeoxyglucose f18 and Peritoneal Carcinomatosis
Article | Year |
---|---|
Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reading; Retrospective Studies; Whole Body Imaging | 2019 |
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; False Negative Reactions; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Salpingo-oophorectomy; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2019 |
Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Pseudomyxoma Peritonei; Recurrence | 2016 |
Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
141 other study(ies) available for fluorodeoxyglucose f18 and Peritoneal Carcinomatosis
Article | Year |
---|---|
Characterizing omental PET/CT findings for differentiating tuberculous peritonitis from peritoneal carcinomatosis.
Topics: Fluorodeoxyglucose F18; Humans; Omentum; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Standard of Care | 2023 |
68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in a Case of Peutz-Jeghers Syndrome.
Topics: Fluorodeoxyglucose F18; Humans; Intestinal Polyps; Peritoneal Neoplasms; Peutz-Jeghers Syndrome; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Combining Diffusion-Weighted Imaging and T2-Weighted Imaging to Delineate Tumorous Tissue in Peritoneal Carcinomatosis: A Comparative Study with 18F-Fluoro-Deoxyglucose Positron Emission Tomography with Computed Tomography (FDG PET/CT).
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Beyond the
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Standard of Care | 2022 |
Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis on 68 Ga-FAPI-04 and 18 F-FDG PET/CT.
Topics: Adult; Ascites; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Tuberculosis | 2022 |
[Hypermetabolic multifocal steatohepatitis: a rare case of [18F]FDG PET/CT false positive mimicking a metastatic carcinomatosis].
Topics: Aged; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Clinical Value of PET.CT Based on Big Data in Colorectal and Peritoneal Metastatic Cancer.
Topics: alpha-Fetoproteins; Big Data; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
FDG-PET/MRI for the preoperative diagnosis and staging of peritoneal carcinomatosis: a prospective multireader pilot study.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
Editorial Comment: Use of
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
[A Case of Peritoneal Recurrence from Ascending Colon Cancer Successfully Treated with Laparoscopic Concomitant Right Seminal Vesiculectomy in Low Anterior Resection].
Topics: Colon, Ascending; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Peritoneal Neoplasms | 2022 |
Malignant Peritoneal Mesothelioma With Butterfly-Shaped Muscle Metastasis: 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma, Malignant; Muscles; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Teratoma; Young Adult | 2023 |
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Favorable Outcome of Repeated Salvage Surgeries for Rare Metastasis to the Ligamentum Teres Hepatis and the Upper Abdominal Wall in a Stage IV Gastric Cancer Patient.
Topics: Abdominal Wall; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Peritoneal Neoplasms; Round Ligament of Liver; Stomach Neoplasms | 2023 |
Diffuse peritoneal carcinomatosis and Sister Mary Joseph nodule in ovarian carcinoma - exquisite demonstration of the peritoneal reflections on [18F]FDG PET/CT.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sister Mary Joseph's Nodule | 2023 |
Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fallopian Tubes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Can [
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies | 2020 |
Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden | 2020 |
18F-FDG Uptake of Localized Malignant Peritoneal Mesothelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Large Idiopathic Mesenteric Necrotizing Granuloma Mimicking Metastatic Disease on FDG PET/CT.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma; Humans; Male; Mouth Neoplasms; Necrosis; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Abdominal Tuberculosis Mimicking Cancer Clinically and on Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) Imaging: A Two-Case Series.
Topics: Aged; Cholangiocarcinoma; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Tuberculosis, Miliary | 2020 |
The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment: A retrospective clinical study.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2020 |
18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
Topics: Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Omentum; Palliative Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival; Tomography, X-Ray Computed | 2020 |
Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis.
Topics: Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
A Case of Localized Malignant Peritoneal Mesothelioma Evaluated by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2020 |
Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; France; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2020 |
68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
Topics: Carcinoma; Endopeptidases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gelatinases; Humans; Image-Guided Biopsy; Male; Membrane Proteins; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Serine Endopeptidases; Stomach Neoplasms | 2020 |
Concurrent Liver and Mesentery Primary Extraosseous Multiple Myeloma on 18F-FDG PET/CT.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mesentery; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
[Disseminated Bone Marrow Carcinomatosis from Breast Cancer Improved by Capecitabine-A Clinical Case Report].
Topics: Bone Marrow; Breast Neoplasms; Capecitabine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Cytoreduction Surgical Procedures; Diffusion Magnetic Resonance Imaging; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Validation of
Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Reproducibility of Results; Survival Analysis; Tomography, X-Ray Computed | 2021 |
Lateral Hepatic Fissure Peritoneal Carcinomatosis as a Pitfall for Hepatic Metastasis of Advanced Ovarian Cancer.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2021 |
Peritoneal carcinomatosis from signet-ring cell adenocarcinoma of the appendix.
Topics: Appendiceal Neoplasms; Carcinoma, Signet Ring Cell; Colonoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Topics: Adult; Aged; Carcinosarcoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Colon, Descending; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Jejunum; Laparotomy; Male; Mesentery; Neoplasm Recurrence, Local; Neoplasm Staging; Panniculitis, Peritoneal; Peritoneal Neoplasms; Peritoneum; Prognosis; Tomography, X-Ray Computed | 2017 |
Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Topics: Contrast Media; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2018 |
The value of
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Retroperitoneal Fibrosis; Sensitivity and Specificity | 2018 |
18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma.
Topics: Aged; Aged, 80 and over; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2018 |
Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2018 |
IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
Topics: Adult; Autoimmune Diseases; Carcinoma; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies | 2018 |
Case of Solitary Peritoneal Metastasis From Atypical Bronchopulmonary Carcinoid on 18F-FDG PET/CT.
Topics: Adult; Biopsy, Fine-Needle; Bronchi; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Topics: Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Pseudomyxoma Peritonei; Radiopharmaceuticals; Survival Rate | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
A Rare Case of Giant Intraperitoneal Lipoma Found Incidentally on
Topics: Adult; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lipoma; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Focal Peritoneal Mesothelioma Demonstrated on FDG PET/CT.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Multimodal Imaging; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
FDG-PET/CT assessment of misty mesentery: feasibility for distinguishing viable mesenteric malignancy from stable conditions.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Mesentery; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Treatment Outcome | 2013 |
Multiple distant adenomyosis mimicking carcinomatosis on FDG PET/CT.
Topics: Adenomyosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gynecologic Surgical Procedures; Humans; Metrorrhagia; Middle Aged; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2014 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2016 |
Transposed ovary mimicking a peritoneal implant on FDG PET/CT in a patient with carcinoma of the rectum.
Topics: Adult; Carcinoma; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT.
Topics: Adult; Aged; Carcinoma; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
Normal-sized ovary carcinoma syndrome (NOCS) detected with FDG-PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Peritoneal Neoplasms; Positron-Emission Tomography; Regression Analysis; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multidetector Computed Tomography; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Organs at Risk; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Cytoreduction Surgical Procedures; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
FDG PET/CT Imaging of an Isolated Recurrence in the Eyelid of a Patient With Follicular Lymphoma.
Topics: Aged, 80 and over; Eye Neoplasms; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Treatment Outcome | 2016 |
Abdominal Kaposiform Hemangioendothelioma Associated With Lymphangiomatosis Involving Mesentery and Ileum: A Case Report of MRI, CT, and 18F-FDG PET/CT Findings.
Topics: Abdominal Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Ileal Neoplasms; Kasabach-Merritt Syndrome; Lymphangioma; Magnetic Resonance Imaging; Mesentery; Multimodal Imaging; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Kaposi; Tomography, X-Ray Computed; Young Adult | 2016 |
FDG PET/CT in Peritoneal Metastasis From Prostate Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Topics: Adult; Aged; Carcinoma; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
Topics: Aged; Carcinoma, Transitional Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvis; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Primary mesenteric neuroendocrine tumor that changed its internal composition from cystic to solid: a case report.
Topics: Aged; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Mesentery; Neuroendocrine Tumors; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2017 |
PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Pati
Topics: Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; South Australia; Survival Rate | 2018 |
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2017 |
The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mesothelioma; Mesothelioma, Cystic; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT.
Topics: Carbonic Anhydrases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis | 2008 |
FDG uptake in parahepatic brown fat mimics peritoneal carcinomatosis in a malignant ovarian germ cell tumor: resolution with temperature control.
Topics: Adipose Tissue, Brown; Carcinoma, Embryonal; Child; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heating; Humans; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis.
Topics: Aged; Ascites; CA-125 Antigen; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
(18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Neoplasm Staging; Patient Selection; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Surgical Procedures, Operative; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Topics: Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2010 |
Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Pseudomyxoma Peritonei; Radiopharmaceuticals | 2010 |
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.
Topics: Air; Animals; Autoradiography; Biological Transport; Carbon Dioxide; Cell Proliferation; Female; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; HT29 Cells; Humans; Hypoxia; Mice; Nitroimidazoles; Oxygen; Peritoneal Neoplasms; Respiration | 2010 |
CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings.
Topics: Adult; Contrast Media; Desmoplastic Small Round Cell Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mesentery; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Hepatitis C-related primary effusion lymphoma of the pleura and peritoneum, imaged with F-18 FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Hepatitis C; Humans; Lymphoma, Primary Effusion; Male; Peritoneal Neoplasms; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Use of FDG-PET imaging for patients with disseminated cancer of the appendix.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Appendiceal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Survival Analysis | 2010 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Reply to: Use of FDG PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy: some considerations.
Topics: Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Inflammation; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence | 2011 |
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET.
Topics: Animals; Biological Transport; Diffusion; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Macrophages; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Positron-Emission Tomography | 2011 |
Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prognosis; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sarcoma; Survival Analysis; Treatment Outcome | 2012 |
Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
Topics: Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18F-FDG uptake in diffuse peritoneal lymphomatosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Tomography, X-Ray Computed | 2012 |
Peritoneal lymphomatosis found on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Detecting peritoneal dissemination of ovarian cancer in mice by DWIBS.
Topics: Animals; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Motion; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Respiration; X-Ray Microtomography | 2013 |
Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Ergocalciferols; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Transplantation, Heterologous | 2012 |
FDG-PET/CT findings of peritoneal lymphomatosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancer.
Topics: Adult; Aged; Carbonated Water; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Time Factors; Tomography, X-Ray Computed | 2013 |
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.
Topics: Aged; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracoscopy; Tomography, X-Ray Computed | 2013 |
Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
"Straight line" sign of diffuse peritoneal carcinomatosis on sagittal FDG positron emission tomographic images.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images.
Topics: Aged; Asbestos; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Peritoneal carcinomatosis: role of (18)F-FDG PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Mesothelial; Ovarian Neoplasms; Peritoneal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2003 |
Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2005 |
Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Invasiveness; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?].
Topics: Bile Duct Neoplasms; Cholestasis, Intrahepatic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematoporphyrin Photoradiation; Hepatic Duct, Common; Humans; Klatskin Tumor; Male; Neoplasm Staging; Outcome Assessment, Health Care; Ovarian Neoplasms; Palliative Care; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies | 2005 |
[A case of peritoneal malignant mesothelioma that FDG-PET was useful for a supporting diagnosis].
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Mesenteric panniculitis in oncologic patients: PET-CT findings.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Mesentery; Middle Aged; Panniculitis, Peritoneal; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2006 |
Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Paraneoplastic Syndromes; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
The straight line sign.
Topics: Constriction, Pathologic; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2006 |
Mesenteric fibromatosis as a potential source of false-positive interpretation of FDG-PET: report of a case.
Topics: False Positive Reactions; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Mesentery; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Topics: Abdominal Neoplasms; Adult; Aged; Colonic Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Abdominal Tuberculosis: peritoneal involvement shown by F-18 FDG PET.
Topics: Abdomen; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Peritonitis, Tuberculous; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis.
Topics: Adult; Carbon; Diagnosis, Differential; Extravasation of Diagnostic and Therapeutic Materials; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Mitomycin; Neoplasm, Residual; Particle Size; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
[A case of peritoneal metastasis from retroperitoneal yolk sac tumor diagnosed by 67Ga-scan and 18F-FDG-PET].
Topics: Adult; Deoxyglucose; Endodermal Sinus Tumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, Emission-Computed | 1995 |
Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Peritoneal Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report.
Topics: Adult; CA-125 Antigen; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2000 |
Metastatic peritoneal seeding patterns demonstrated by FDG positron emission tomographic imaging.
Topics: Adenocarcinoma; Aged; Ascitic Fluid; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Seeding; Peritoneal Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Topics: Adenocarcinoma, Mucinous; Adenofibroma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma.
Topics: Castleman Disease; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Mesentery; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2001 |